AASTROM BIOSCIENCES Stock Price
$0.5601 
Change:
0.01 0.91% Volume:
3,444
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 0.5691 | Todays Low: 0.5501 | Open: 0.5501 | Last Close: 0.56
52 Wk High: 2.33 | 52 Wk Low: 0.5203 | Todays Pivot: 0.56 | Pre market open: 0.72
Sector: 
Online News For Aastrom Biosciences
|
Curis Inc. (NASDAQ:CRIS) up by 5.33%, Aastrom Biosciences Inc (NASDAQ ... - GSPInsider
Tue, 14 May 2013 06:41Aastrom Biosciences Inc (NASDAQ:ASTM) is down by 0.82% in Monday's trading and closed at $0.595, after starting its day with a value of $0.58. The share ranged in between $0.58 and $0.60 throughout the day. At a price of $0.600 and 45.68 million shares ...
|
|
Aastrom Biosciences Reports First Quarter 2013 Financial Results - MarketWatch (press release)
Wed, 08 May 2013 20:00ANN ARBOR, May 08, 2013 (GLOBE NEWSWIRE via COMTEX) -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) , the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today ...
|
|
Aastrom Biosciences's Neutral Rating Reaffirmed at Zacks (ASTM) - Mideast Time
Mon, 13 May 2013 22:31Aastrom Biosciences logo Zacks reaffirmed their neutral rating on shares of Aastrom Biosciences (NASDAQ: ASTM) in a research note released on Thursday morning, Stock Ratings Network reports. They currently have a $1.00 price target on the stock.
|
|
Stocks Down For The Day: Ambac Financial Group Inc. (OTCMKTS:ABKFQ ... - NIS
Tue, 30 Apr 2013 01:33Aastrom Biosciences Inc (NASDAQ:ASTM) fell 10.87% at $0.615 after trading 771,408 shares. The company is the leader in developing patient-specific, expanded multicellular therapies for use in the treatment of patients with severe, chronic ...
|
|
For every action, there is an equal and opposite reaction, as good news doesn ... - Proactive Investors USA & Canada
Fri, 24 May 2013 19:02Prior to joining PrimeraDx, Myles was chief financial officer and senior vice president of Pressure BioSciences, a Nasdaq-listed life science tools company. At Pressure BioSciences he oversaw all compliance activities, transformed the investor ...
|
|
MitoStem expands exec staff with new, veteran CEO - Model D
Tue, 21 May 2013 04:01Audrey Hutter formerly worked as a vice president at Aastrom Biosciences in Ann Arbor during the early 2000s. She will help MitoStem's team of three employees and four interns raise $1 million in angel investor funding this year. "We need further ...
|
ASTM Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Aastrom Biosciences quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ASTM to choose from. Visit here to build your stock quote widget »
